Decibel Cannabis Company Inc. (CVE:DB) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

In This Article:

Shareholders in Decibel Cannabis Company Inc. (CVE:DB) had a terrible week, as shares crashed 22% to CA$0.07 in the week since its latest quarterly results. Revenues were CA$21m, and Decibel Cannabis was a dismal 12% short of estimates. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

See our latest analysis for Decibel Cannabis

earnings-and-revenue-growth
earnings-and-revenue-growth

After the latest results, the consensus from Decibel Cannabis' three analysts is for revenues of CA$98.5m in 2024, which would reflect a definite 12% decline in revenue compared to the last year of performance. Earnings are expected to improve, with Decibel Cannabis forecast to report a statutory profit of CA$0.02 per share. Yet prior to the latest earnings, the analysts had been anticipated revenues of CA$108.3m and earnings per share (EPS) of CA$0.025 in 2024. The analysts seem less optimistic after the recent results, reducing their revenue forecasts and making a pretty serious reduction to earnings per share numbers.

The analysts made no major changes to their price target of CA$0.37, suggesting the downgrades are not expected to have a long-term impact on Decibel Cannabis' valuation. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. There are some variant perceptions on Decibel Cannabis, with the most bullish analyst valuing it at CA$0.50 and the most bearish at CA$0.25 per share. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. We would highlight that revenue is expected to reverse, with a forecast 16% annualised decline to the end of 2024. That is a notable change from historical growth of 49% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 9.6% annually for the foreseeable future. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - Decibel Cannabis is expected to lag the wider industry.